1. Introduction {#sec1-metabolites-09-00206}
===============

Chili pepper (*Capsicum* spp.) is one of the most important crops worldwide. It is used as a main ingredient for many dishes in different cultures, such as Asian, Latin-American, and Mediterranean cultures, due to its organoleptic properties \[[@B1-metabolites-09-00206]\]. There are 40 accepted chili species but only five are considered domesticated: *C. annuum*, *C. chinense* Jacq, *C. frutescens*, *C. baccatum*, and *C. pubescens* \[[@B2-metabolites-09-00206]\]. In 2017, 36 million tons of chili peppers were produced globally, with Mexico being the second largest producer \[[@B3-metabolites-09-00206]\]. Wild pepper populations of Tabasco pepper (*C. frutescens* L.) and *C. annuum* can be found in some states of Mexico, increasing the relevance for collecting and characterizing these species as resources for the breeding of cultivated peppers \[[@B4-metabolites-09-00206],[@B5-metabolites-09-00206]\]. Previous studies have extensively described metabolite diversity in *C. annuum* \[[@B6-metabolites-09-00206],[@B7-metabolites-09-00206]\] but very little is known on *C. chinense* and *C. frutescens*. Most of these studies have undertaken a targeted approach, where the main focus has been to quantitate for specific metabolites, such as capsiate, dihydrocapsiate, capsaicin, dihydrocapsaicin, carotenoids, fatty acids, and amino acids \[[@B8-metabolites-09-00206],[@B9-metabolites-09-00206]\]. To date, there are no studies with a comprehensive global profiling of tissue specific in *C. frutescens* and *C. chinense*.

*Capsicum* species are known to be rich in compounds such as capsaicinoids, capsinoids, carotenoids, flavonoids, vitamins, essential oils, and other phytochemicals, which provide a unique taste, aromatic properties, and health benefits \[[@B10-metabolites-09-00206],[@B11-metabolites-09-00206],[@B12-metabolites-09-00206],[@B13-metabolites-09-00206],[@B14-metabolites-09-00206]\]. Capsaicinoids consist mainly of two congeners, capsaicin and dihydrocapsaicin. Capsinoids also have two major analogues, capsiate and dihydrocapsiate. However, there are structural differences: Capsaicinoids are fatty acid amides linked with vanillylamine, whereas capsinoids are fatty acid esters linked to vanillyl alcohol \[[@B15-metabolites-09-00206],[@B16-metabolites-09-00206]\]. Several compounds identified in the *Capsicum* species have been studied, because the medicinal potential examples of these compounds are icariside E5, capsosides, and capsianosides \[[@B17-metabolites-09-00206]\]; hydroxycinnamic derivatives, O-glycosides of quercetin, luteolin, and chrysoeriol \[[@B7-metabolites-09-00206]\]. The reported medicinal benefits are related to areas, such as anti-inflammatory \[[@B18-metabolites-09-00206]\], anti-cancer \[[@B19-metabolites-09-00206]\], anti-microbial, antioxidant properties \[[@B1-metabolites-09-00206],[@B20-metabolites-09-00206],[@B21-metabolites-09-00206]\], and those with weight-loss properties \[[@B22-metabolites-09-00206]\]. In addition, some epidemiological studies of a number of these antioxidants reported that they possess anti-atherosclerotic, antitumor, antimutagenic or anticarcinogenic activity \[[@B23-metabolites-09-00206],[@B24-metabolites-09-00206],[@B25-metabolites-09-00206]\]. It may be that these properties have the ability to help us to address the identification, isolation, and production of nutraceutical compounds or new natural medicinal compounds.

Nevertheless, the location and relative abundance of these metabolites and their precursors in different parts of the chili pepper fruit, such as the pericarp, placenta and seed, remain unclear. It is known that some compounds are synthesized and accumulated into specific tissues in the *Capsicum* genus \[[@B1-metabolites-09-00206],[@B26-metabolites-09-00206]\]; for example, capsaicin is synthesized mainly in the placenta \[[@B27-metabolites-09-00206],[@B28-metabolites-09-00206]\], while anthocyanins are described as being accumulated in pericarp during fruit development \[[@B29-metabolites-09-00206]\]. Materska, reported a placental and pericarp comparison in chili pepper fruit, where placenta was the richest in flavonoids, while the pericarp presented a larger diversity in glycosylated compounds. Despite this, little is known about the tissue specific spatial-temporal location of other classes of compounds and products of the secondary metabolism in *Capsicum* fruits \[[@B30-metabolites-09-00206]\]. Investigating the metabolic diversity on fruit tissues is essential in order to gain a comprehensive understanding of the function of specific parts of the fruit at the fundamental level. Consequently, this will enable the possible exploitation of natural products either for pharmaceutical or food products. In the past, these have been done with histochemical methods, by staining tissues sections with various chemical to reveal the presence of specific compounds either by visual or microscope inspection \[[@B31-metabolites-09-00206]\].

Metabolomics is defined as the comprehensive analysis of all low molecular weight organic compounds (\<1500 Da) in a biological system \[[@B32-metabolites-09-00206]\]. Mass spectrometry has become the most widely applied platform for metabolomics, due to the wide range of molecules that can be analyzed on a single run \[[@B33-metabolites-09-00206]\]. Global profiling or non-targeted mass spectrometry-based metabolomics have gained importance in the study of crop species and have been applied to investigate potato, tomato, rice, wheat, strawberry, cucumber, and tobacco \[[@B34-metabolites-09-00206],[@B35-metabolites-09-00206],[@B36-metabolites-09-00206],[@B37-metabolites-09-00206]\]. In the field of plant metabolomics, liquid chromatography coupled with electrospray ionization high resolution mass spectrometry (UPLC-ESI-HRMS) has emerged as the technique of choice for the putative identification of metabolites in complex matrices. This technique has been widely used, due to its sensitivity, selectivity, and analysis capability \[[@B38-metabolites-09-00206],[@B39-metabolites-09-00206]\]. Nevertheless, metabolite identification for unknown compounds still remains a big challenge to overcome. In that respect, the recommendations by the Metabolomics Standards Initiative (MSI) recognize five different levels for metabolite confidence annotations. Level 0 requires the full compound 3D structure and stereochemistry information. Levels which are more common include: Level 1 identifications need a confirmation by two orthogonal parameters such as retention time and MS/MS spectrum, normally with match reference standards; and Level 2 requires at least two orthogonal pieces of information, including evidence that excludes all other candidates. Data for Level 2 should describe probable structure and be matched to literature data or databases by diagnostic evidence \[[@B40-metabolites-09-00206]\].

Combining existing bioinformatic tools with high resolution mass spectrometry data can reveal unclear relationships of metabolites and their possible function at a spatial-temporal distribution level. As a first attempt to construct the chili fruit metabolome, we produced a hand curated dataset, that contains 60 putative identified metabolites, which include alkaloids and terpenoids that are unreported in *Capsicum*, with significant differences and relative abundances between three sections (pericarp, placenta, and seed) of Tabasco pepper fruit at the mature red stage, using an UHPLC-QTOF-HRMS platform, combined with the use of Progenesis QI for small molecules, as a tool for the pre-identification of unknown metabolites. Our results underline the global metabolic differences in complexity, mainly based on the secondary metabolism of these fruit parts.

2. Results {#sec2-metabolites-09-00206}
==========

2.1. Non-Targeted Metabolomic Analysis {#sec2dot1-metabolites-09-00206}
--------------------------------------

Our data for two tissues and the seed of Tabasco chili fruit comprised a total of 87 files or chromatograms per ionization mode (positive and negative polarities) as shown in [Figure 1](#metabolites-09-00206-f001){ref-type="fig"} and were uploaded into Progenesis QI. The dataset was first aligned (retention time): Each chromatogram was aligned against each other and automatically compared to a reference profile selected by the software that contained the highest number of features (potential compounds). Then, peak picking was performed by default parameters. A total of 1980 features were detected in the aqueous phase and 1481 were detected in the diethyl ether extract, for both ionization modes. [Figure 1](#metabolites-09-00206-f001){ref-type="fig"} shows a typical chromatographic profile in positive and negative ionization mode of placenta tissue, displaying some representative compounds of chili pepper fruit.

Distribution of the features between parts was compared using principal component analysis (PCA) of loading and score plots describing a significant grouping by part for both extraction phases ([Figure 2](#metabolites-09-00206-f002){ref-type="fig"}). In addition, quality controls (QC samples) were also considered, as shown in [Figure 2](#metabolites-09-00206-f002){ref-type="fig"}. The QC samples cluster tightly in comparison to the total variance in the projection, suggesting a dataset deemed to be of high quality. [Table 1](#metabolites-09-00206-t001){ref-type="table"} and [Table 2](#metabolites-09-00206-t002){ref-type="table"} describe loadings that mostly contribute to principal components for each extraction. Putative organic compounds catalogued as saponins (SPNS), such as Tuberoside J, Matesaponin 5, and Asparagoside B significantly contributed to component 1 in the aqueous phase, while other important features for component 2 belong to flavonoid class (FLV) and SPNS compounds. Furthermore, both components in the organic phase were mainly composed of glycerolipids (GL) and terpenoids (TER), as well as a putative carotenoid, (5cis,5′cis,9cis,11′cis)-1,2,7,7′,8,8′-Hexahydro-1,2-epoxy-ψ, ψ-carotene were important for contribution of component 1 in organic phase.

2.2. Level 1 and 2 Metabolomic Identification Analysis {#sec2dot2-metabolites-09-00206}
------------------------------------------------------

We putatively identified approximately 270 compounds and classified them in 52 compound classes ([Table S1](#app1-metabolites-09-00206){ref-type="app"}). Putative identifications were taken into consideration with a high match score (\>90%). Terpenoids, fatty acids, and glycosylated compounds were the most abundant groups. As was predicted, different capsaicinoid compounds were also detected with a high match score. Alkaloids, carotenoids, saponins, and phenolic compounds were also detected in our study.

Capsaicin and dihydrocapsaicin were validated by matching their retention times and MS/MS spectra with those of the analytical standard (Level 1 identification). Furthermore, commonly reported compounds, such as carotenoids and capsaicin related compounds, were detected and putatively identified in the same manner in our samples ([Figure 3](#metabolites-09-00206-f003){ref-type="fig"}).

2.3. Different Metabolomic Profiles in Capsicum Sections {#sec2dot3-metabolites-09-00206}
--------------------------------------------------------

Based on results from volcano plot comparisons, we found a total of 60 putative compounds with significant differences between the parts of the Tabasco pepper fruit. [Figure 4](#metabolites-09-00206-f004){ref-type="fig"} shows the distribution of features between placenta and pericarp tissues. As was expected \[[@B28-metabolites-09-00206]\], capsaicinoids were more abundant in placenta than pericarp. In contrast, pericarp was richer in glycosylated compounds and terpenoids such as acalyphin, capsiate, and capsidiol. Some significant ions remain unknown that still need to be identified.

After feature screening and putative identification, Venn diagrams were generated ([Figure 5](#metabolites-09-00206-f005){ref-type="fig"}) to show similarities and differences between fruit parts, according to the fold change values obtained in [Table S1](#app1-metabolites-09-00206){ref-type="app"}. Noticeably, around 30% of the complete dataset of identification was shared by all three fruit parts in almost all the extraction solvents, the exception being for the organic phase in the negative ionization mode, which only share 9.32% similarities. As can be seen in the Venn diagrams, a greater number of putative metabolites were identified in the positive ionization mode. Those easily detected in the positive ionization mode were the compound classes alkaloids, carotenoids, fatty acids, glycosylated compounds, terpenoids, and saponins; while in the negative ionization mode amino acid-derivate compounds, sphingolipids, and phospholipids were detected.

Listed in [Table 3](#metabolites-09-00206-t003){ref-type="table"} is the putative identification that presents a differential abundance between fruit parts, including the fragmentation pattern (MS^2^) and adducts for putative annotation. Fold change values are shown in [Table S1](#app1-metabolites-09-00206){ref-type="app"}.

3. Discussion {#sec3-metabolites-09-00206}
=============

The global metabolic comparison between the tissues and seeds of *C. frutescens* showed several feature differences between the pericarp, placenta, and seed. The Level 1 and 2 confidence metabolite annotations allowed us to assign a putative identification to these ions. Around 30% of metabolites were shared between all three parts. Compounds related to the primary metabolism showed few significant differences, they included amino acid related compounds, fatty acids, and phospholipids. As shown in the Venn diagram ([Figure 5](#metabolites-09-00206-f005){ref-type="fig"}) and [Table S1](#app1-metabolites-09-00206){ref-type="app"}, placenta and pericarp have the biggest compound class diversity. Significantly, the seeds presented a higher number of putative identifications, and these were primarily saponins, terpenes, and fatty acids.

Pericarp compound classes were mainly composed of glycosylated compounds and terpenoids. Complementary to these findings, Materska demonstrated that chili pepper pericarp is abundant in glycosylated compounds \[[@B30-metabolites-09-00206]\]. Likewise, terpenoids were distributed in the whole fruit but pericarp showed a slightly higher proportion of them. These compounds are highly abundant in spices and herbs and give a wide range on the aroma and flavor spectrum \[[@B1-metabolites-09-00206]\]. Similarly, terpenoids have been described as showing antibiotic properties \[[@B41-metabolites-09-00206]\] and have been used in fragrances \[[@B42-metabolites-09-00206]\].

Placental tissue showed a large number of previously reported compounds with bioactivity, mainly capsaicin- and capsinoids-related compounds. In addition, alkaloids and tocopherols were present, a fact that is in agreement with current literature \[[@B28-metabolites-09-00206],[@B30-metabolites-09-00206]\]. Found to be abundant in this fruit compartment were 6-O-acetylaustroinulin (terpenoid) and Myrciacitrin V (flavonoid) and they have not been reported in the *Capsicum* fruit.

The compounds found in chili seeds were predominantly fatty acids (3,16-Dihydroxypalmitate, Sterculynic acid) and saponins (Capsicoside A, Eleutheroside L and Tragopogonsaponin F) where they function as reserve nutrients for embryo development and propagation \[[@B43-metabolites-09-00206]\]. Moreover, seeds showed the presence of terpenes (Ursolic acid 3-\[glucosyl-(1-\>4)-xyloside\]) which are known to function as a natural promoter of predation and, as a consequence, a seed disperser \[[@B44-metabolites-09-00206]\]. Ritota et al. (2010) reported an abundance of fatty acids in sweet pepper species by nuclear magnetic resonance spectroscopy, in which polyunsaturated fatty acids were easily detected and pre-identified \[[@B6-metabolites-09-00206]\].

Our results were consistent with previously reported findings regarding the large diversity of secondary metabolites in fruits of *Capsicum* species and the non-targeted metabolomics profiling of Solanaceae \[[@B10-metabolites-09-00206],[@B26-metabolites-09-00206],[@B39-metabolites-09-00206],[@B45-metabolites-09-00206],[@B46-metabolites-09-00206],[@B47-metabolites-09-00206],[@B48-metabolites-09-00206]\]. Furthermore, new compounds, such as Myrciacitrin V, Feruloyl-β-sitosterol, 6-O-acetylaustroinulin and others, were putatively annotated as statistically significant in specific fruit parts.

Capsaicin, Dihydrocapsaicin, and capsaicinoids derivatives mainly accumulate in the placenta, as previously reported \[[@B27-metabolites-09-00206],[@B49-metabolites-09-00206]\]. This class of compounds represents the most described and abundant metabolite in this genus and are predominantly known as being responsible for the pungency. Different bioactivity assays have been developed, demonstrating properties of capsaicinoids over different cell lines and metabolism, including as an analgesic and for weight-loss \[[@B22-metabolites-09-00206],[@B50-metabolites-09-00206]\]. Large abundance of capsaicinoids in the chili fruit placenta was proposed by Tewksbury and Nabhan (2001), who suggest that capsaicin selectively discourages vertebrate predators (capsaicin has been found to repel or poison mammals) without deterring more effective and important seed dispersers, such as birds. \[[@B51-metabolites-09-00206]\].

A variety of new compounds in *Capsicum* genus, also reported in different species, were detected in pericarp, including isopimaric acid \[[@B41-metabolites-09-00206]\], which is a terpenoid with bioactive properties. Additionally, other compounds such as Pedalitin \[[@B52-metabolites-09-00206]\], Xi-8-acetonyldihydrosanguinarine \[[@B53-metabolites-09-00206]\], Pratenol B \[[@B54-metabolites-09-00206]\], Uralenneoside \[[@B55-metabolites-09-00206]\] were detected in pericarp and have been previously reported as bioactive compounds. Quercetin 3-(6″-malonyl-glucoside) is an anthocyanin-related compound that has not been reported in pepper fruit, but this compound class is well known to be localized mainly in pericarp \[[@B56-metabolites-09-00206],[@B57-metabolites-09-00206]\], due to its involvement as a protection system against solar damage in plants and to attract potential pollinators \[[@B29-metabolites-09-00206]\].

New putative compounds in placental tissue, such as Lycopodane \[[@B58-metabolites-09-00206]\], 2,4-Pentadiynylbenzene \[[@B59-metabolites-09-00206]\], Myrciacitrin V \[[@B60-metabolites-09-00206]\], Cinncassiol C \[[@B61-metabolites-09-00206]\], and 6-O-acetylaustroinulin \[[@B62-metabolites-09-00206]\] have been reported as bioactive compounds, supporting the nutraceutical properties of chili pepper against metabolic disorders.

The existence of terpenes in seeds may result in different aromas that have been shown to firstly attract birds to mature fruits during the day \[[@B63-metabolites-09-00206]\] and secondly, to promote the dispersal of seeds. This function supports the ecological relationship between birds and chili pepper fruits, attracting the most beneficial vertebrate predators \[[@B51-metabolites-09-00206]\].

In summary, the non-targeted LC-MS metabolomics method that was developed in this study is shown to be a powerful tool for the putative identification of tissue-specific secondary metabolites at the red mature stage of chili pepper fruit. The use of databases available online gave rise to a faster comprehensive elucidation of global characteristics of a complex matrix than more traditional phytochemical studies. Nutraceutical, aroma, flavor, and new compounds that have not been reported before were putatively identified and related to pericarp, placenta or seeds of *C. frutescens*. As presented here, some of these compounds have been reported with bioactivity properties, supporting empirical properties of pepper fruit that have been known for centuries. The procedure developed here will be utilized for further studies in our laboratory, including to enable the exploration of comparisons between wild cultivars of chili pepper fruit with their cultivated counterparts and for the further understanding of secondary metabolism in this crop. We recommend that complementary analysis should be carried out to confirm structural elucidation. In addition, compound isolation and bioactivity properties should be considered in future studies.

4. Materials and Methods {#sec4-metabolites-09-00206}
========================

4.1. Plant Material and Dissection of Tissues and Seed {#sec4dot1-metabolites-09-00206}
------------------------------------------------------

Seeds of Tabasco pepper (*C. frutescens* L.) were treated with 3% hypochlorite solution. Plants were grown in optimum conditions (30--32 °C), at greenhouse facilities between June and September of 2016. Fruits from different plants were collected at 60 DPA (red ripe stage), washed with deionized water and immediately frozen with liquid nitrogen and stored at −80 °C until dissection and analysis.

Five biological replicates (plants) were considered for the experiment and three fruits per plant were collected. Each fruit was first placed into dry ice to facilitate hand dissection into pericarp, placenta, and seed using a sterile scalpel. All fruit parts were ground using a ball mill (Retsch MM301) under cold conditions and applying liquid nitrogen.

4.2. Chemicals, Reagents, and Standards {#sec4dot2-metabolites-09-00206}
---------------------------------------

All chemicals and reagents were purchased from AccesoLab S.A. de C.V. (Mexico, Mexico). Capsaicin and dihydrocapsaicin analytical standards, formic acid, methanol, acetonitrile were HPLC grade and purchased from Sigma--Aldrich (Mexico, Mexico).

4.3. Sample Extraction and UHPLC-MS Analysis {#sec4dot3-metabolites-09-00206}
--------------------------------------------

For metabolite extraction, the method employed was adapted from Matyash \[[@B64-metabolites-09-00206]\] as follows: Methanol, 1.5 mL, was added to 100 mg of sample in a test tube and vortexed for 1 min, then, 5 mL of diethyl ether was added. The mixture was incubated with gentle stirring for one hour at room temperature. Next, 1.5 mL of ultra-pure water (18 Ω, milli-Q system) was added and mixed vigorously for a further minute then kept at room temperature for 10 min to allow phase separation. After that, the sample was centrifuged at 1000 × g for 10 min. Aqueous and organic layers were recovered separately and vacuum dried (miVac®, Genevac) at 30 °C for 30 min and finally kept at −80 °C until further analysis.

Three quality control (QC) samples were prepared to account for instrument drift and system calibration during analysis in UHPLC-QTOF-HRMS; each QC sample was prepared by mixing homogenously all sample extracts into a new single vial, in both separated phases containing polar and non-polar compounds. QC samples were distributed at the beginning, middle, and end of the injection run list. Analytical standards of capsaicin and dihydrocapsaicin were injected under the same conditions as samples. Extraction blanks were also considered during the experiment.

For LC-MS analysis, all samples (including QC, analytical standards and blank extraction) were resuspended in 1 mL of acetonitrile/ultra-pure water 50:50 (*v/v*) and filtered through a membrane of 0.2 µm (PTFE, Agilent Technologies, Santa Clara, USA). Samples were injected according to a randomized list order on an UPLC® (Acquity class I, Waters, Milford, CA, USA) coupled with an orthogonal QTOF (SYNAPT G1 HDMS, Waters, Milford, CA, USA) mass spectrometer. Chromatographic separation was achieved on a reversed phase CSH C18 column (2.1 mm × 150 mm, 1.7 µm, Waters, Milford, USA) maintained at 30 °C during chromatographic separation. Auto-sampling of 10 µL per sample was injected. Compounds were eluted using ultra-pure water with 0.1% (*v/v*) formic acid (solvent A) and acetonitrile with 0.1% (*v/v*) formic acid (solvent B) with a flow rate of 0.3 mL/min with the following gradient program: From 0.5 to 30 min, 1--75% B; 30 to 31 min, 75% B; 31 to 31.5 min, 75--100% B; 31.5 to 34.5, 100% B; 34.5 to 34.6, 100-1% B; 34.6 to 36 min, 1% B. The mass spectrometer mass range was set from 50 to 1500 Da. Both ionization modes were injected separated. For negative electrospray ionization (ESI) mode, the conditions were set as follows: Capillary voltage 2 kV; cone voltage 40 V; source temperature 150 °C; cone gas flow 20 L/h; desolvation temperature 350 °C; desolvation gas flow 600 L/h. For the positive ESI mode: Capillary voltage 3 kV; cone voltage 40 V; source temperature 130 °C; desolvation temperature 350 °C; desolvation gas flow 700 L/h. Leucine-Enkephalin (2 ng/mL) was infused as LockSpray reference internal mass calibrant at a flow rate of 5 µL/min and its signal was monitored every 10 s. The data format was collected in a continuum mode with a MS scan time of 1.5 s. In both the positive and negative ionization mode, data were acquired in MS^E^ experiments; using Argon as the collision gas with a collision energy in the trap region of 6 eV (Function 1, low energy) and ranged from 20--40 eV (Function 2, high voltage).

4.4. Data Analysis {#sec4dot4-metabolites-09-00206}
------------------

Raw data was imported to Progenesis QI for small molecules software (Non-Linear Dynamics, Waters, Milford, MA, USA) for automatic alignment, normalization, deconvolution, and compound pre-identification over all samples separating the aqueous and organic phases. The RT range was limited from 0.5 to 35 min for pre-identification method. Pre-identification was performed using Chemspider Databases (PlantCyc, Plant Metabolic Network, KEGG, HMDB and ChEBI) and with an in-house database with a minimum match of 90% for precursor ions, MS/MS data and isotope distribution was included for increasing match score values. Statistics and graphics were performed using EZinfo 3.0 (Waters, Milford, MA, USA) and R (3.3.3v, Vienna, Austria) \[[@B65-metabolites-09-00206]\] software. Compounds were grouped according to their compound classes. The resulting data was first mean centered and scaled to Pareto and then submitted to a principal component analysis (PCA) using the first three components. Results were analyzed using one-way ANOVA and q-values were established using the false discovery rate (FDR \< 0.01) to correct multiple comparisons by the Benjamini--Hochberg procedure \[[@B66-metabolites-09-00206]\].

We thank Fernando Hernández-Godinez (Computational Biology Lab), María Esperanza Anaya-Gil (Metabolomics Lab), and Neftalí Ochoa-Alejo for their assistance, support, and suggestions during the experiment.

The following are available online at <https://www.mdpi.com/2218-1989/9/10/206/s1>, Table S1: Putative identification.xlsx.
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![(**a**) Base peak intensity chromatographic profile of placenta tissue from chili pepper fruit on a Charged Surface Hybrid (CSH) C18 column obtained with Electrospray Ionization (ESI) positive mode on a mass range from 100 to 1500. 1. 2-\[(1H-Indol-3-ylacetyl) amino\]-4-methylpentanoate; 2. Indole-3-acetamide; 3. L-cis-Cyclo (aspartylphenylalanyl); 4. Capsicosin; 5. Yamogenintetroside B; 6. Capsaicin; 7. Dihydrocapsaicin; 8. Homodihydrocapsaicin; 9. β-Carotinal. (**b**) Base peak intensity chromatographic profile of placenta tissue from chili pepper fruit on a CSH C18 column obtained with ESI negative mode. 10. Oleandrigenin monodigitoxoside; 11. β-[d]{.smallcaps}-fructofuranosyl 6-O-octanoyl-α-[d]{.smallcaps}-glucopyranoside; 12. β-(1-\>6)-galactotriitol; 13. (2S,3R)-2-Azaniumyl-3-hydroxyoctadecyl phosphate.](metabolites-09-00206-g001){#metabolites-09-00206-f001}

![(**a**) Principal Component Analysis (PCA) Bi-plot of loadings (features: crosses) obtained in ESI positive mode and scores (samples: colored circles) extracted with methanol:water phase (component 1:33.10%; component 2: 15.72%; loadings = 1294 features; n = 26); (**b**) PCA Bi-plot of loadings (features: crosses) and scores (samples: colored circles) extracted with diethyl ether phase (component 1:37.15%; component 2: 15.14%; loadings = 1391 features; n = 24).](metabolites-09-00206-g002){#metabolites-09-00206-f002}

![Mass spectrum of most common compounds in Tabasco chili pepper using Ultra High Pressure Liquid Chromatography MSMS Quadrupole Time of Flight (UHPLC-MS^2^ Q-TOF; collision energy ramp: 20--40 eV) ESI positive ionization mode of placenta tissue, as putatively identified by Progenesis QI for small molecules. (**a**) Capsaicin; (**b**) β-carotinal; and (**c**) dihydrocapsaicin.](metabolites-09-00206-g003){#metabolites-09-00206-f003}

![Volcano plot comparison of relative abundance between tissues of 1394 features in ESI positive ionization mode: Placenta (left), and pericarp (right), unchanged (green); one-way ANOVA *p* = 0.05 (dotted line) Y axis: p value, X axis: fold change.](metabolites-09-00206-g004){#metabolites-09-00206-f004}

![Venn diagrams of the complete dataset of putative metabolites in different fruit parts at the red mature stage of Tabasco chili pepper (*C. frutescens*); labels are in percent and number of metabolites.](metabolites-09-00206-g005){#metabolites-09-00206-f005}

metabolites-09-00206-t001_Table 1

###### 

Loadings most contributing to principal components for the aqueous phase.

  Putative Identification                                                                                                                                                                          Class   PC1
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------- --------
  Tuberoside J                                                                                                                                                                                     SPNS    0.2012
  Asparagoside B                                                                                                                                                                                   SPNS    0.1939
  Matesaponin 5                                                                                                                                                                                    SPNS    0.1871
  Oleanolic acid 3-O-\[O-β-[d]{.smallcaps}-glucopyranosyl-(1-\>4)-O-β-[d]{.smallcaps}-glucopyranosyl-(1-\>3)-O-α-[l]{.smallcaps}-rhamnopyranosyl- (1-\>2)-α -[l]{.smallcaps}-arabinopyranoside\]   SPNS    0.1822
  Capsicosin                                                                                                                                                                                       SPNS    0.1650
                                                                                                                                                                                                           PC2
  (3″-Apiosyl-6″-malonyl) astragalin                                                                                                                                                               FLV     0.1401
  Pratenol B                                                                                                                                                                                       BZD     0.0881
  Asparagoside B                                                                                                                                                                                   SPNS    0.0750
  Matesaponin 5                                                                                                                                                                                    SPNS    0.0673
  Kaempferol 3-xylosylglucoside                                                                                                                                                                    FLV     0.0658

PC1: Principal Component 1; PC2: Principal Component 2; BZD: benzoyl derivate; FLV: flavonoid; SPNS: saponin.

metabolites-09-00206-t002_Table 2

###### 

Loading most contributing to principal components for the organic phase.

  Putative Identification                                                    Class   PC1
  -------------------------------------------------------------------------- ------- ---------
  Abietane                                                                   TER     0.1450
  (5cis,5′cis,9cis,11′cis)-1,2,7,7′,8,8′-Hexahydro-1,2-epoxy-ψ, ψ-carotene   CARO    0.1429
  Lycoperoside D                                                             SPNS    0.1324
  Phyllohydroquinone                                                         TER     0.1302
  2-Caprylooleomyristin                                                      GL      −0.0796
                                                                                     PC2
  α,α′-Trehalose 6-mycolate                                                  GL      0.1505
  2-Caprylooleomyristin                                                      GL      0.1226
  MG(14:0/0:0/0:0)                                                           GL      −0.1284
  Uralenneoside                                                              BZD     −0.0757
  Abietane                                                                   TER     0.0719

PC1: Principal Component 1; PC2: principal Component 2; BZD: benzoyl derivate; Caro: carotenoid; GL: Glycerolipids; SPNS: saponin; TER: terpenoid.

metabolites-09-00206-t003_Table 3

###### 

Differential putative identifications in parts of Tabasco pepper fruit by UHPLC-MS^2^ in both ESI modes.

  Compound Name                                                                                                                                                                                  Formula              Class   Adduct                  Precursor (*m/z*)   Fragments (*m/z*)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------- ------- ----------------------- ------------------- ---------------------------------------------------------------------------------------------------
  α-campholenaldehyde                                                                                                                                                                            C~10~H~16~O          TER     \[M + H − H~2~O\] +     135.1180            109.1021(3.7)
  Jasmolone                                                                                                                                                                                      C~11~H~16~O~2~       JASM    \[M + H − 2H~2~O\] +    145.1027            133.1026(4.0), 121.1024(3.3), 107.0864(3.5)
  2,4-Pentadiynylbenzene                                                                                                                                                                         C~11~H~8~            BZD     \[2M + NH4\] +          298.1669            177.0684(2.8), 145.0399(1.6), 117.0428(1.9)
  Uralenneoside                                                                                                                                                                                  C~12~H~14~O~8~       BZD     \[M + H\] +             287.0755            287.0741(63.6), 285.0609(0.4), 257.0637(2.6), 203.0493(0.5), 153.0300(1.45), 135.0542(0.1)
  Synephrine acetonide                                                                                                                                                                           C~12~H~17~NO~2~      BZD     \[2M + FA − H\] -       459.2565            208.2805(8.9)
  Cuscohygrine                                                                                                                                                                                   C~13~H~24~N~2~O      AK      \[M + H\] +             225.1977            197.1340(5.5), 183.1184 (5.6)
  Acalyphin                                                                                                                                                                                      C~14~H~20~N~2~O~9~   GC      \[M + Na\] +            383.1044            325.0952(1.3), 299.0774(4.6), 165.0311(0.3)
  Pratenol B                                                                                                                                                                                     C~15~H~12~O~7~       BZD     \[M + H − H~2~O\] +     287.0546            153.0195(2.8), 131.0512 (2.3)
  Lycopodane                                                                                                                                                                                     C~15~H~25~N          AK      \[M + H − 2H~2~O\] +    220.3782            184.1841(5.8)
  Pedalitin                                                                                                                                                                                      C~16~H~12~O~7~       FLV     \[M + H − H~2~O\] +     299.0570            299.0568(7.3), 165.0197(0.5)
  Nordihydrocapsaicin                                                                                                                                                                            C~17~H~27~NO~3~      CAPS    \[M+H\] +               294.2055            285.2240(3.6), 257.2282(2.8), 189.1653(3.9)
  Nerolidyl acetate                                                                                                                                                                              C~17~H~28~O~2~       TER     \[M + H − 2H~2~O\] +    229.1966            161.134 (12.7)
  Capsaicin                                                                                                                                                                                      C~18~H~27~NO~3~      CAPS    \[M + H\] +             306.2075            182.1559(0.2), 137.0605(15.4), 122.0371(5.8)
  Dihydrocapsaicin                                                                                                                                                                               C~18~H~29~NO~3~      CAPS    \[M + H\] +             308.2240            9137.061 (5.5)
  Artocarbene                                                                                                                                                                                    C~19~H~18~O~4~       PPN     \[M + H\] +             311.1301            175.0771(2.5), 169.0756(3.5), 163.0764(0.9), 160.0537(0.7), 137.0614(2.2), 131.0511(2.0)
  1-(4-hydroxyphenyl)-7-phenyl-(6E)-6-hepten-3-ol                                                                                                                                                C~19~H~22~O~2~       PPN     \[M + Cl\] −            317.1345            131.0808 (0.3)
  Sterculynic acid                                                                                                                                                                               C~19~H~30~O~2~       FAT     \[M + H − H~2~O\] +     273.2235            273.2220(60.9), 255.2121(53.2), 173.1339(6.3), 163.0616(4.3), 161.1336(28.8), 147.1183(8.0)
  Kaempferol 3-O-arabinoside                                                                                                                                                                     C~20~H~18~O~10~      FLV     \[M + H − 2H~2~O\] +    383.0783            325.0730(4.0), 299.0568(7.3), 165.0197(0.5)
  all-trans-3,4-Didehydroretinoate                                                                                                                                                               C~20~H~26~O~2~       PRN     \[M + H\] +             281.1929            181.1024(21.3), 165.0731(19.1), 157.1027(23.0), 155.0870(37.3), 145.1027(27.6), 128.0636(66.9)
  Cinncassiol C                                                                                                                                                                                  C~20~H~28~O~7~       TER     \[M + H − H~2~O\] +     363.1781            332.1368(0.6), 314.1253(0.5), 222.1141(0.6), 136.0677(2.1), 135.0456(0.2), 119.0495(0.8)
  Isopimaric acid                                                                                                                                                                                C~20~H~30~O~2~       TER     \[M + H − 2H~2~O\] +    285.2239            284.2974(0.7), 257.2282(2.8)
  2′-Hydroxyisoorientin                                                                                                                                                                          C~21~H~20~O~12~      FLV     \[M + H\] +             465.1051            303.0512 (7.4)
  5,7,3′-trihydroxy-3,5′-dimethoxy-2′-(3′-methylbut-2-enyl)flavone                                                                                                                               C~22~H~22~O~7~       FLV     \[M + H\] +             399.1472            381.1379 (0.9)
  Vestitone 7-glucoside                                                                                                                                                                          C~22~H~26~O~9~       PPN     \[M + ACN + H\] +       417.1577            221.0831 (2.6)
  6-O-Acetylaustroinulin                                                                                                                                                                         C~22~H~36~O~4~       TER     \[M + ACN + Na\] +      787.5307            733.4879 (7.0)
  xi-8-Acetonyldihydrosanguinarine                                                                                                                                                               C~23~H~19~NO~5~      AK      \[M + H − H~2~O\] +     372.1245            344.1288(0.8), 149.0352(0.3)
  Quercetin 3-(6″-malonyl-glucoside)                                                                                                                                                             C~24~H~22~O~15~      FLV     \[M + H\] +             551.1061            303.0514 (23.3)
  12′-apo-β-carotenal                                                                                                                                                                            C~25~H~34~O          TER     \[2M + FA − H\] −       745.5259            685.5227(231.2), 539.4294(47.0)
  Kaempferol 3-xylosylglucoside                                                                                                                                                                  C~26~H~28~O~15~      FLV     \[M + H\] +             581.1525            341.2486(1.6), 287.0557(49.5), 153.0195(2.8), 131.0512(2.3)
  11′-Carboxy-α-tocopherol                                                                                                                                                                       C~26~H~42~O~4~       TPHE    \[M + H\] +             419.3222            177.1023 (0.5)
  β-tocopherol                                                                                                                                                                                   C~28~H~48~O~2~       TPHE    \[2M − H\] -            831.7267            417.6959(90.2)
  Amarogentin                                                                                                                                                                                    C~29~H~30~O~13~      GC      \[M + NH4\] +           604.2051            325.073(4.0), 299.0568(7.3), 165.0197(0.5)
  Rhamnazin 3-rutinoside                                                                                                                                                                         C~29~H~34~O~16~      FLV     \[M + 2Na − H\] +       683.1485            303.0514 (23.3)
  Myrciacitrin V                                                                                                                                                                                 C~30~H~30~O~13~      FLV     \[M + ACN + H\] +       640.2098            151.0407 (5.4)
  Bryononic acid                                                                                                                                                                                 C~30~H~46~O~3~       CBN     \[M + ACN + Na\] +      518.3645            358.1972(0.5), 342.2300(1.5), 320.2464(1.8), 222.1338(0.3), 196.1848(0.3)
  3,7-Dihydroxy-25-methoxycucurbita-5,23-dien-19-al                                                                                                                                              C~31~H~50~O~4~       STR     \[M + Cl\] −            521.3404            485.7277(21.0)
  Capsianoside I                                                                                                                                                                                 C~32~H~52~O~14~      TER     \[M + Na\] +            683.3298            683.3291(4.4), 365.1088(1.6), 363.0929(1.6), 271.2444(7.5)
  Diosgenin 3-O-beta-[d]{.smallcaps}-glucoside                                                                                                                                                   C~33~H~52~O~8~       TER     \[M + H\] +             577.3759            468.2101(67.0), 441.1756(9.8), 415.3230(23.2), 397.3135(4.5), 397.1857(3.8), 271.0622(4.8)
  Kidjoranin-3-O-β-digitoxopyranoside                                                                                                                                                            C~36~H~48~O~10~      SPNS    \[M − H~2~O − H\] −     621.3029            621.3011(167.6), 579.2889(8.2), 285.1144(46.0), 255.0975(5.6)
  Feruloyl-β-sitosterol                                                                                                                                                                          C~39~H~58~O~4~       TER     \[2M + Hac − H\] −      1239.9012           1239.893(28.0), 887.5754(11.0)
  Ubiquinol-6                                                                                                                                                                                    C~39~H~60~O~4~       PRN     \[M + Na\] +            615.4544            394.3743(20.0), 322.2779(2.0), 310.3341(3.8), 134.1078(2.0)
  Fistuloside A                                                                                                                                                                                  C~39~H~62~O~13~      SPNS    \[M + H\] +             739.4309            577.3766(32.5), 468.2101(67.0), 441.1756(9.8), 415.3230(23.2), 397.3135 (4.5),271.0622(4.8)
  Nigroxanthin                                                                                                                                                                                   C~40~H~54~O~2~       TER     \[M + 2Na − H\] +       611.3841            467.2684(1.0), 449.3285(2.3), 305.2134(4.5), 287.2032(2.6), 269.1927(1.9)
  Ursolic acid 3-\[glucosyl-(1-\>4)-xyloside\]                                                                                                                                                   C~41~H~66~O~12~      TER     \[M + Na\] +            773.4399            773.4389(4.5), 686.3793(2.1), 611.3844(5.0), 449.3285(2.3), 305.2134(4.5), 287.2032(2.6)
  Melilotoside B                                                                                                                                                                                 C~41~H~68~O~12~      TER     \[M + H\] +             753.4203            267.1773 (0.4)
  Licoricesaponin C2                                                                                                                                                                             C~42~H~62~O~15~      TER     \[M + Na\] +            829.3952            829.3948(32.4), 723.3561(3.4),624.3786(4.6),310.1940(1.3), 250.1564(8.8), 146.0618(1.3)
  Tuberoside L                                                                                                                                                                                   C~51~H~84~O~23~      SPNS    \[M + H\] +             1065.5627           670.3848(1.4), 611.3847(1.6), 449.3291(1.6), 432.3226(0.5)
  Yamogenintetroside B                                                                                                                                                                           C~52~H~86~O~22~      SPNS    \[M + 2Na − H\] +       1107.5319           854.4602(7.0), 762.4256(11.1), 559.4917(1.7), 541.4820(2.5), 426.3396(5.1), 309.1197(1.9)
  Oleanolic acid 3-O-\[O-β-[d]{.smallcaps}-glucopyranosyl-(1-\>4)-O-β-[d]{.smallcaps}-glucopyranosyl-(1-\>3)-O-α-[l]{.smallcaps}-rhamnopyranosyl-(1-\>2)-α-[l]{.smallcaps}-arabinopyranoside\]   C~53~H~86~O~21~      TER     \[M + Na\] +            1081.5464           773.4401(1.3), 611.3846(3.4), 449.3298(3.2), 153.0195(6.5)
  Tragopogonsaponin F                                                                                                                                                                            C~56~H~80~O~21~      SPNS    \[M + CH~3~OH + H\] +   1121.5515           786.4322 (43.4)
  Trigofoenoside G                                                                                                                                                                               C~56~H~92~O~27~      SPNS    \[M + H\] +             1197.5995           1197.5994(31.3), 829.3948(32.4), 723.3561(3.4), 624.3786(4.6), 338.1889(1.5), 250.1564(8.8)
  Hovenoside D                                                                                                                                                                                   C~57~H~92~O~26~      TER     \[M + CH~3~OH + H\] +   1225.6028           1210.6307(124.9), 1064.5708(55.2), 870.4542(25.2), 442.3347(11.2), 325.1173(14.4), 301.0726(19.0)
  Capsicosin                                                                                                                                                                                     C~57~H~94~O~29~      TER     \[M + H\] +             1243.6144           595.3883(18.9), 433.3333(18.6), 415.3237(9.2), 289.2185(18.0), 271.2091(10.8), 161.1340(12.7)
  Eleutheroside L                                                                                                                                                                                C~59~H~96~O~25~      SPNS    \[M + Na\] +            1227.6129           932.493(12.4), 399.3288(8.4), 285.2599(2.2)
  β-[l]{.smallcaps}-arabinose 1-phosphate(2-)                                                                                                                                                    C~5~H~9~O~8~P-2      GC      \[M + Cl\] −            262.9693            262.9688(2.6), 218.9505(4.6)
  Capsicoside A                                                                                                                                                                                  C~63~H~106~O~35~     SPNS    \[M + H − 2H~2~O\] +    1387.6618           901.4882(5.1), 739.4320(24.5), 577.3766(32.5), 468.2101(67.0), 441.1756(9.8), 415.3230(23.2)
  Matesaponin 5                                                                                                                                                                                  C~65~H~10~6O~31~     SPNS    \[M + Na\] +            1405.6713           757.4389(195.6), 595.3839(200.6), 451.2716(56.9), 289.2162(151.2), 271.2075(66.5), 253.1970(56.8)
  Pyridoxamine                                                                                                                                                                                   C~8~H~12~N~2~O~2~    PYR     \[M+H−H~2~O\] +         151.0872            135.0247 (0.3)
  3-\[3,4-Dihydroxy-2-(hydroxymethyl)-1-pyrrolidinyl\]propanamide                                                                                                                                C~8~H~16~N~2~O~4~    AK      \[M + H − H~2~O\] +     187.1093            175.1117(1.3), 155.0443(0.2), 116.0711(1.3), 112.0767(0.5), 109.0296(0.9)
  2,4-Nonadienal                                                                                                                                                                                 C~9~H~14~O           CBN     \[M + K\] +             177.0683            169.1144(11.7), 157.1133(15.3), 155.0982(17.7), 153.0822(13.1), 142.0889(25.6), 128.0724(24.6)

AK: Alkaloids; BZD: benzoyl derivate; CAPS: capsaicinoids; CBN: carbonyl derivate; FAT: fatty acids; FLV: flavonoids; GC: glycoside compounds; Jasm: jasmones; PPN: phenylpropanoids; PYR: pyrazines; SPNS: saponins; TER: terpenoids; TPHE: tocopherols. Relative abundance values of fragments ions are in brackets.
